QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.089102v1 316/1/79    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Josserand, V. Articles by Tavitian, B. Search for Related Content PubMed PubMed Citation Articles by Josserand, V. Articles by Tavitian, B.

NEUROPHARMACOLOGY

Evaluation of Drug Penetration into the Brain: A Double Study by in Vivo Imaging with Positron Emission Tomography and Using an in Vitro Model of the Human Blood-Brain Barrier

Commissariat à l'Energie Atomique (CEA), Service Hospitalier Frédéric Joliot, Orsay, France; Institut National de la Santé et de la Recherche Médicale ERM 0103 (V.J., B.J., F.Du., R.B., B.T.) and Radiochemistry Group (B.d.B., B.K., F.H., F.Do.), Orsay, France; CEA, Service de Pharmacologie et d'Immunologie, Gif-sur-Yvette, France (H.P., E.E., A.M.); Service de Neuropathologie, Hôpital Sainte Anne, Paris, France (F.B., C.D.-D.); and Service de Neurochirurgie, Hôpital Sainte Anne, Paris, France (F.C.)

The blood-brain barrier (BBB) permeabilities of 11 compounds were measured both in vitro with a newly developed coculture-based model of human BBB and in vivo with positron emission tomography (PET). The 11 compounds were fluoropyridinyl derivatives labeled with the positron-emitter fluorine-18, [¹⁸F]F-A-85380 [2-[¹⁸F]fluoro-3-[2(S)-2 azetidinylmethoxy]pyridine], and 10 selected N-substituted-azetidinyl and pyrrolidinyl closely related [¹⁸F]fluoropyridinyl derivatives (including [N'-aromatic/aliphatic]-thioureas, -ureas, and -amides). The in vitro BBB model, a new coculture system of primary human brain endothelial cells and astrocytes, was used to measure the permeability coefficient for each compound. Dynamic PET studies were performed in rats with the same compounds, and a two-compartment model analysis was used to calculate their in vivo permeability coefficients. The 11 derivatives differed in their degree of BBB passage and transport mechanism. The analysis of PET data showed a significant cerebral uptake for six derivatives, for which the in vitro evaluation indicated active influx or free diffusion. Five derivatives displayed low in vivo cerebral uptake, in agreement with the observation of an in vitro active efflux. Overall, there was a remarkable correlation between the in vitro and in vivo permeability coefficients (r = 0.99). This double study proves a close correlationship between the assessment of the BBB passage in vitro and in vivo. The in vitro model of human BBB offers the possibility of subtle discrimination of various BBB permeability degrees and transport mechanisms. Conversely, small animal PET imaging appears suitable to screen directly in vivo brain targeting of drugs or radiopharmaceutical candidates.

Address correspondence to: Dr. Aloïse Mabondzo, CEA, Laboratoire d'Etudes du Métabolisme des Médicaments, Service de Pharmacologie et d'Immunologie, DRM/DSV, Btiment 136, 91191 Gif sur Yvette Cedex, France. E-mail: Alo\|[iuml ]\|se.Mabondzo{at}cea.fr